Alvotech (ALVO) Profit After Tax (2021 - 2026)
Alvotech's (ALVO) quarterly Profit After Tax came in at -$66.8 million in Q2 2026, down 308.57% on a YoY basis from $32.0 million in Q2 2025, and down 6587.48% quarter-over-quarter from $1.0 million in Q1 2026.
Analysis
Alvotech (ALVO) Profit After Tax (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Profit After Tax for 6 consecutive years, with -$66.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Profit After Tax fell 308.57% year-over-year to -$66.8 million; the trailing twelve-month figure through Jun 2026 stood at -$230.7 million (up 9.55% YoY), and the FY2025 full-year result was $31.5 million, up 113.58% from the prior year.
- Profit After Tax fell to -$66.8 million in Q2 2026 per ALVO's latest filing, from $1.0 million in the prior quarter.
- Across five years, Profit After Tax topped out at $329.1 million in Q2 2022 and bottomed at -$551.7 million in Q1 2023.
- Historically, Profit After Tax has averaged -$131.6 million across 5 years, with a median of -$125.9 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Profit After Tax plunged 405.97% in 2022, then soared 161.12% in 2025.
- Over 5 years, Profit After Tax stood at -$513.6 million in 2022, then slipped by 7.43% to -$551.7 million in 2023, then soared by 57.98% to -$231.9 million in 2024, then jumped by 161.12% to $141.7 million in 2025, then tumbled by 147.15% to -$66.8 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$66.8 million, $1.0 million, and $141.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -576.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -118.80 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 45.93 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 69.61 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 260.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 24.71 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -66.82 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 30.35 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 1.97 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | -880,561.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -66.82 Mn |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 141.72 Mn |
| Sep 30, 2025 | -306.62 Mn |
| Jun 30, 2025 | 32.04 Mn |
| Mar 31, 2025 | 109.68 Mn |
| Dec 31, 2024 | -231.86 Mn |
| Sep 30, 2024 | -164.90 Mn |
| Jun 30, 2024 | 218.73 Mn |
| Mar 31, 2024 | -218.73 Mn |
| Dec 31, 2023 | -551.73 Mn |
| Aug 31, 2023 | -86.85 Mn |
| Jun 30, 2023 | 189.33 Mn |
| Mar 20, 2023 | -551.73 Mn |
| Dec 31, 2022 | -513.58 Mn |
| Aug 31, 2022 | -184.47 Mn |
| Jun 30, 2022 | 329.08 Mn |
| Mar 20, 2022 | -513.58 Mn |
| Dec 31, 2021 | -101.50 Mn |
| Sep 30, 2021 | -81.32 Mn |